410 related articles for article (PubMed ID: 33089892)
1. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
2. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
3. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.
Khan S; Tudur Smith C; Williamson P; Sutton R
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD000553. PubMed ID: 17054131
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
5. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.
Ede CJ; Nikolova D; Brand M
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011717. PubMed ID: 30073663
[TBL] [Abstract][Full Text] [Related]
6. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
7. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Roberts D; Best LM; Freeman SC; Sutton AJ; Cooper NJ; Arunan S; Begum T; Williams NR; Walshaw D; Milne EJ; Tapp M; Csenar M; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013155. PubMed ID: 33837526
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.
Ríos Castellanos E; Seron P; Gisbert JP; Bonfill Cosp X
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010180. PubMed ID: 25966446
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
[TBL] [Abstract][Full Text] [Related]
10. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
[TBL] [Abstract][Full Text] [Related]
11. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis.
Zhou GP; Sun LY; Wei L; Qu W; Zeng ZG; Liu Y; Jiang YZ; Zhu ZJ
Chin Med J (Engl); 2019 May; 132(9):1087-1099. PubMed ID: 30913064
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome.
Gonzalez-Garay AG; Serralde-Zúñiga AE; Velasco Hidalgo L; Flores García NC; Aguirre-Salgado MI
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011039. PubMed ID: 38235907
[TBL] [Abstract][Full Text] [Related]
13. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
[TBL] [Abstract][Full Text] [Related]
14. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
Kravetz D
J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
[TBL] [Abstract][Full Text] [Related]
15. [Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?].
Grønbaek H; Thomsen KL; Ott P; Vilstrup H
Ugeskr Laeger; 2007 Aug; 169(34):2761-3. PubMed ID: 17878011
[No Abstract] [Full Text] [Related]
16. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
[TBL] [Abstract][Full Text] [Related]
17. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
Vadera S; Yong CWK; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
[TBL] [Abstract][Full Text] [Related]
18. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Colli A; Fraquelli M; Prati D; Casazza G
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013532. PubMed ID: 37278488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
